nodes	percent_of_prediction	percent_of_DWPC	metapath
Triazolam—CYP2C9—Estropipate—osteoporosis	0.0613	0.0941	CbGbCtD
Triazolam—CYP2C8—Raloxifene—osteoporosis	0.0586	0.0901	CbGbCtD
Triazolam—CYP2C8—Ethinyl Estradiol—osteoporosis	0.0566	0.087	CbGbCtD
Triazolam—CYP3A7—Estradiol—osteoporosis	0.0506	0.0777	CbGbCtD
Triazolam—CYP3A7-CYP3A51P—Estradiol—osteoporosis	0.0506	0.0777	CbGbCtD
Triazolam—CYP2C8—Cholecalciferol—osteoporosis	0.0452	0.0695	CbGbCtD
Triazolam—CYP3A5—Estradiol—osteoporosis	0.0379	0.0583	CbGbCtD
Triazolam—CYP2C8—Estradiol—osteoporosis	0.0365	0.056	CbGbCtD
Triazolam—CYP3A4—Estropipate—osteoporosis	0.0356	0.0547	CbGbCtD
Triazolam—CYP3A4—Calcitriol—osteoporosis	0.0356	0.0547	CbGbCtD
Triazolam—CYP2C9—Cholecalciferol—osteoporosis	0.0316	0.0485	CbGbCtD
Triazolam—CYP3A4—Ergocalciferol—osteoporosis	0.0285	0.0438	CbGbCtD
Triazolam—CYP2C9—Estradiol—osteoporosis	0.0254	0.0391	CbGbCtD
Triazolam—CYP3A4—Raloxifene—osteoporosis	0.0238	0.0365	CbGbCtD
Triazolam—CYP3A4—Ethinyl Estradiol—osteoporosis	0.023	0.0353	CbGbCtD
Triazolam—CYP3A4—Cholecalciferol—osteoporosis	0.0183	0.0282	CbGbCtD
Triazolam—CYP3A4—Conjugated Estrogens—osteoporosis	0.0168	0.0259	CbGbCtD
Triazolam—CYP3A4—Estradiol—osteoporosis	0.0148	0.0227	CbGbCtD
Triazolam—Dysgeusia—Zoledronate—osteoporosis	0.000627	0.0018	CcSEcCtD
Triazolam—Anxiety—Risedronate—osteoporosis	0.000626	0.00179	CcSEcCtD
Triazolam—Constipation—Ibandronate—osteoporosis	0.000625	0.00179	CcSEcCtD
Triazolam—Pain—Ibandronate—osteoporosis	0.000625	0.00179	CcSEcCtD
Triazolam—Pruritus—Etidronic acid—osteoporosis	0.000623	0.00178	CcSEcCtD
Triazolam—Gastrointestinal pain—Estropipate—osteoporosis	0.000623	0.00178	CcSEcCtD
Triazolam—Decreased appetite—Calcitriol—osteoporosis	0.000622	0.00178	CcSEcCtD
Triazolam—Feeling abnormal—Alendronate—osteoporosis	0.000618	0.00177	CcSEcCtD
Triazolam—Oedema—Ethinyl Estradiol—osteoporosis	0.000618	0.00177	CcSEcCtD
Triazolam—Erythema—Conjugated Estrogens—osteoporosis	0.000617	0.00177	CcSEcCtD
Triazolam—Loss of consciousness—Pamidronate—osteoporosis	0.000616	0.00176	CcSEcCtD
Triazolam—Muscle spasms—Zoledronate—osteoporosis	0.000616	0.00176	CcSEcCtD
Triazolam—Jaundice—Estradiol—osteoporosis	0.000616	0.00176	CcSEcCtD
Triazolam—Dry mouth—Risedronate—osteoporosis	0.000614	0.00176	CcSEcCtD
Triazolam—Gastrointestinal pain—Alendronate—osteoporosis	0.000614	0.00176	CcSEcCtD
Triazolam—Pain—Calcitriol—osteoporosis	0.000612	0.00175	CcSEcCtD
Triazolam—Constipation—Calcitriol—osteoporosis	0.000612	0.00175	CcSEcCtD
Triazolam—Flatulence—Conjugated Estrogens—osteoporosis	0.000608	0.00174	CcSEcCtD
Triazolam—Hypertension—Pamidronate—osteoporosis	0.000606	0.00173	CcSEcCtD
Triazolam—Tension—Conjugated Estrogens—osteoporosis	0.000605	0.00173	CcSEcCtD
Triazolam—Dysgeusia—Conjugated Estrogens—osteoporosis	0.000604	0.00173	CcSEcCtD
Triazolam—Gastrointestinal pain—Raloxifene—osteoporosis	0.000604	0.00173	CcSEcCtD
Triazolam—Diarrhoea—Etidronic acid—osteoporosis	0.000603	0.00173	CcSEcCtD
Triazolam—Abdominal pain—Estropipate—osteoporosis	0.000602	0.00172	CcSEcCtD
Triazolam—Feeling abnormal—Ibandronate—osteoporosis	0.000602	0.00172	CcSEcCtD
Triazolam—Tremor—Zoledronate—osteoporosis	0.0006	0.00172	CcSEcCtD
Triazolam—Nervousness—Conjugated Estrogens—osteoporosis	0.000599	0.00172	CcSEcCtD
Triazolam—Gastrointestinal pain—Ibandronate—osteoporosis	0.000597	0.00171	CcSEcCtD
Triazolam—Anxiety—Pamidronate—osteoporosis	0.000595	0.0017	CcSEcCtD
Triazolam—Ill-defined disorder—Zoledronate—osteoporosis	0.000594	0.0017	CcSEcCtD
Triazolam—Abdominal pain—Alendronate—osteoporosis	0.000593	0.0017	CcSEcCtD
Triazolam—Muscle spasms—Conjugated Estrogens—osteoporosis	0.000593	0.0017	CcSEcCtD
Triazolam—Shock—Risedronate—osteoporosis	0.000592	0.0017	CcSEcCtD
Triazolam—Discomfort—Pamidronate—osteoporosis	0.00059	0.00169	CcSEcCtD
Triazolam—Agitation—Zoledronate—osteoporosis	0.000589	0.00169	CcSEcCtD
Triazolam—Gastrointestinal pain—Calcitriol—osteoporosis	0.000585	0.00167	CcSEcCtD
Triazolam—Abdominal pain—Raloxifene—osteoporosis	0.000583	0.00167	CcSEcCtD
Triazolam—Malaise—Zoledronate—osteoporosis	0.000578	0.00165	CcSEcCtD
Triazolam—Abdominal pain—Ibandronate—osteoporosis	0.000578	0.00165	CcSEcCtD
Triazolam—Confusional state—Pamidronate—osteoporosis	0.000577	0.00165	CcSEcCtD
Triazolam—Syncope—Zoledronate—osteoporosis	0.000575	0.00164	CcSEcCtD
Triazolam—Oedema—Pamidronate—osteoporosis	0.000572	0.00164	CcSEcCtD
Triazolam—Palpitations—Zoledronate—osteoporosis	0.000566	0.00162	CcSEcCtD
Triazolam—Abdominal pain—Calcitriol—osteoporosis	0.000565	0.00162	CcSEcCtD
Triazolam—Shock—Pamidronate—osteoporosis	0.000563	0.00161	CcSEcCtD
Triazolam—Loss of consciousness—Zoledronate—osteoporosis	0.000563	0.00161	CcSEcCtD
Triazolam—Hypersensitivity—Estropipate—osteoporosis	0.000561	0.00161	CcSEcCtD
Triazolam—Vomiting—Etidronic acid—osteoporosis	0.00056	0.0016	CcSEcCtD
Triazolam—Tachycardia—Pamidronate—osteoporosis	0.000559	0.0016	CcSEcCtD
Triazolam—Dermatitis—Etidronic acid—osteoporosis	0.000555	0.00159	CcSEcCtD
Triazolam—Hyperhidrosis—Pamidronate—osteoporosis	0.000553	0.00158	CcSEcCtD
Triazolam—Syncope—Conjugated Estrogens—osteoporosis	0.000553	0.00158	CcSEcCtD
Triazolam—Hypertension—Zoledronate—osteoporosis	0.000553	0.00158	CcSEcCtD
Triazolam—Hypersensitivity—Alendronate—osteoporosis	0.000553	0.00158	CcSEcCtD
Triazolam—Headache—Etidronic acid—osteoporosis	0.000552	0.00158	CcSEcCtD
Triazolam—Asthenia—Estropipate—osteoporosis	0.000547	0.00156	CcSEcCtD
Triazolam—Visual impairment—Estradiol—osteoporosis	0.000547	0.00156	CcSEcCtD
Triazolam—Anorexia—Pamidronate—osteoporosis	0.000546	0.00156	CcSEcCtD
Triazolam—Chest pain—Zoledronate—osteoporosis	0.000545	0.00156	CcSEcCtD
Triazolam—Palpitations—Conjugated Estrogens—osteoporosis	0.000545	0.00156	CcSEcCtD
Triazolam—Insomnia—Risedronate—osteoporosis	0.000545	0.00156	CcSEcCtD
Triazolam—Anxiety—Zoledronate—osteoporosis	0.000544	0.00156	CcSEcCtD
Triazolam—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.000542	0.00155	CcSEcCtD
Triazolam—Paraesthesia—Risedronate—osteoporosis	0.000541	0.00155	CcSEcCtD
Triazolam—Pruritus—Estropipate—osteoporosis	0.000539	0.00154	CcSEcCtD
Triazolam—Discomfort—Zoledronate—osteoporosis	0.000539	0.00154	CcSEcCtD
Triazolam—Asthenia—Alendronate—osteoporosis	0.000538	0.00154	CcSEcCtD
Triazolam—Hypersensitivity—Ibandronate—osteoporosis	0.000538	0.00154	CcSEcCtD
Triazolam—Dyspnoea—Risedronate—osteoporosis	0.000537	0.00154	CcSEcCtD
Triazolam—Dry mouth—Zoledronate—osteoporosis	0.000533	0.00153	CcSEcCtD
Triazolam—Fatigue—Ethinyl Estradiol—osteoporosis	0.000532	0.00152	CcSEcCtD
Triazolam—Pruritus—Alendronate—osteoporosis	0.000531	0.00152	CcSEcCtD
Triazolam—Tinnitus—Estradiol—osteoporosis	0.000529	0.00151	CcSEcCtD
Triazolam—Constipation—Ethinyl Estradiol—osteoporosis	0.000528	0.00151	CcSEcCtD
Triazolam—Confusional state—Zoledronate—osteoporosis	0.000527	0.00151	CcSEcCtD
Triazolam—Hypersensitivity—Calcitriol—osteoporosis	0.000527	0.00151	CcSEcCtD
Triazolam—Chest pain—Conjugated Estrogens—osteoporosis	0.000525	0.0015	CcSEcCtD
Triazolam—Asthenia—Ibandronate—osteoporosis	0.000524	0.0015	CcSEcCtD
Triazolam—Anxiety—Conjugated Estrogens—osteoporosis	0.000523	0.0015	CcSEcCtD
Triazolam—Nausea—Etidronic acid—osteoporosis	0.000523	0.0015	CcSEcCtD
Triazolam—Oedema—Zoledronate—osteoporosis	0.000523	0.0015	CcSEcCtD
Triazolam—Diarrhoea—Estropipate—osteoporosis	0.000521	0.00149	CcSEcCtD
Triazolam—Fatigue—Risedronate—osteoporosis	0.000519	0.00149	CcSEcCtD
Triazolam—Insomnia—Pamidronate—osteoporosis	0.000518	0.00148	CcSEcCtD
Triazolam—Pruritus—Ibandronate—osteoporosis	0.000517	0.00148	CcSEcCtD
Triazolam—Pain—Risedronate—osteoporosis	0.000515	0.00147	CcSEcCtD
Triazolam—Constipation—Risedronate—osteoporosis	0.000515	0.00147	CcSEcCtD
Triazolam—Shock—Zoledronate—osteoporosis	0.000514	0.00147	CcSEcCtD
Triazolam—Paraesthesia—Pamidronate—osteoporosis	0.000514	0.00147	CcSEcCtD
Triazolam—Diarrhoea—Alendronate—osteoporosis	0.000513	0.00147	CcSEcCtD
Triazolam—Asthenia—Calcitriol—osteoporosis	0.000513	0.00147	CcSEcCtD
Triazolam—Dyspnoea—Pamidronate—osteoporosis	0.00051	0.00146	CcSEcCtD
Triazolam—Tachycardia—Zoledronate—osteoporosis	0.00051	0.00146	CcSEcCtD
Triazolam—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000509	0.00146	CcSEcCtD
Triazolam—Somnolence—Pamidronate—osteoporosis	0.000509	0.00146	CcSEcCtD
Triazolam—Pruritus—Calcitriol—osteoporosis	0.000506	0.00145	CcSEcCtD
Triazolam—Hyperhidrosis—Zoledronate—osteoporosis	0.000505	0.00145	CcSEcCtD
Triazolam—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000505	0.00145	CcSEcCtD
Triazolam—Diarrhoea—Raloxifene—osteoporosis	0.000505	0.00145	CcSEcCtD
Triazolam—Dizziness—Estropipate—osteoporosis	0.000504	0.00144	CcSEcCtD
Triazolam—Oedema—Conjugated Estrogens—osteoporosis	0.000503	0.00144	CcSEcCtD
Triazolam—Diarrhoea—Ibandronate—osteoporosis	0.0005	0.00143	CcSEcCtD
Triazolam—Anorexia—Zoledronate—osteoporosis	0.000498	0.00143	CcSEcCtD
Triazolam—Decreased appetite—Pamidronate—osteoporosis	0.000498	0.00142	CcSEcCtD
Triazolam—Dizziness—Alendronate—osteoporosis	0.000496	0.00142	CcSEcCtD
Triazolam—Shock—Conjugated Estrogens—osteoporosis	0.000495	0.00142	CcSEcCtD
Triazolam—Erythema—Estradiol—osteoporosis	0.000494	0.00141	CcSEcCtD
Triazolam—Fatigue—Pamidronate—osteoporosis	0.000494	0.00141	CcSEcCtD
Triazolam—Gastrointestinal pain—Risedronate—osteoporosis	0.000492	0.00141	CcSEcCtD
Triazolam—Tachycardia—Conjugated Estrogens—osteoporosis	0.000491	0.00141	CcSEcCtD
Triazolam—Pain—Pamidronate—osteoporosis	0.000489	0.0014	CcSEcCtD
Triazolam—Constipation—Pamidronate—osteoporosis	0.000489	0.0014	CcSEcCtD
Triazolam—Diarrhoea—Calcitriol—osteoporosis	0.000489	0.0014	CcSEcCtD
Triazolam—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000488	0.0014	CcSEcCtD
Triazolam—Dizziness—Raloxifene—osteoporosis	0.000488	0.0014	CcSEcCtD
Triazolam—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000487	0.00139	CcSEcCtD
Triazolam—Flatulence—Estradiol—osteoporosis	0.000486	0.00139	CcSEcCtD
Triazolam—Tension—Estradiol—osteoporosis	0.000484	0.00139	CcSEcCtD
Triazolam—Vomiting—Estropipate—osteoporosis	0.000484	0.00139	CcSEcCtD
Triazolam—Dysgeusia—Estradiol—osteoporosis	0.000483	0.00138	CcSEcCtD
Triazolam—Dizziness—Ibandronate—osteoporosis	0.000483	0.00138	CcSEcCtD
Triazolam—Dermatitis—Estropipate—osteoporosis	0.00048	0.00137	CcSEcCtD
Triazolam—Anorexia—Conjugated Estrogens—osteoporosis	0.00048	0.00137	CcSEcCtD
Triazolam—Nervousness—Estradiol—osteoporosis	0.00048	0.00137	CcSEcCtD
Triazolam—Headache—Estropipate—osteoporosis	0.000477	0.00137	CcSEcCtD
Triazolam—Vomiting—Alendronate—osteoporosis	0.000477	0.00137	CcSEcCtD
Triazolam—Abdominal pain—Risedronate—osteoporosis	0.000476	0.00136	CcSEcCtD
Triazolam—Muscle spasms—Estradiol—osteoporosis	0.000475	0.00136	CcSEcCtD
Triazolam—Insomnia—Zoledronate—osteoporosis	0.000473	0.00135	CcSEcCtD
Triazolam—Dermatitis—Alendronate—osteoporosis	0.000473	0.00135	CcSEcCtD
Triazolam—Feeling abnormal—Pamidronate—osteoporosis	0.000472	0.00135	CcSEcCtD
Triazolam—Headache—Alendronate—osteoporosis	0.00047	0.00135	CcSEcCtD
Triazolam—Paraesthesia—Zoledronate—osteoporosis	0.000469	0.00134	CcSEcCtD
Triazolam—Vomiting—Raloxifene—osteoporosis	0.000469	0.00134	CcSEcCtD
Triazolam—Gastrointestinal pain—Pamidronate—osteoporosis	0.000468	0.00134	CcSEcCtD
Triazolam—Dyspnoea—Zoledronate—osteoporosis	0.000466	0.00133	CcSEcCtD
Triazolam—Dermatitis—Raloxifene—osteoporosis	0.000465	0.00133	CcSEcCtD
Triazolam—Somnolence—Zoledronate—osteoporosis	0.000465	0.00133	CcSEcCtD
Triazolam—Vomiting—Ibandronate—osteoporosis	0.000465	0.00133	CcSEcCtD
Triazolam—Tremor—Estradiol—osteoporosis	0.000463	0.00132	CcSEcCtD
Triazolam—Headache—Raloxifene—osteoporosis	0.000462	0.00132	CcSEcCtD
Triazolam—Dermatitis—Ibandronate—osteoporosis	0.00046	0.00132	CcSEcCtD
Triazolam—Ill-defined disorder—Estradiol—osteoporosis	0.000458	0.00131	CcSEcCtD
Triazolam—Headache—Ibandronate—osteoporosis	0.000458	0.00131	CcSEcCtD
Triazolam—Insomnia—Conjugated Estrogens—osteoporosis	0.000455	0.0013	CcSEcCtD
Triazolam—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000455	0.0013	CcSEcCtD
Triazolam—Vomiting—Calcitriol—osteoporosis	0.000455	0.0013	CcSEcCtD
Triazolam—Decreased appetite—Zoledronate—osteoporosis	0.000455	0.0013	CcSEcCtD
Triazolam—Agitation—Estradiol—osteoporosis	0.000454	0.0013	CcSEcCtD
Triazolam—Nausea—Estropipate—osteoporosis	0.000453	0.0013	CcSEcCtD
Triazolam—Abdominal pain—Pamidronate—osteoporosis	0.000453	0.0013	CcSEcCtD
Triazolam—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000452	0.00129	CcSEcCtD
Triazolam—Fatigue—Zoledronate—osteoporosis	0.000451	0.00129	CcSEcCtD
Triazolam—Dermatitis—Calcitriol—osteoporosis	0.000451	0.00129	CcSEcCtD
Triazolam—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000449	0.00128	CcSEcCtD
Triazolam—Headache—Calcitriol—osteoporosis	0.000448	0.00128	CcSEcCtD
Triazolam—Somnolence—Conjugated Estrogens—osteoporosis	0.000448	0.00128	CcSEcCtD
Triazolam—Constipation—Zoledronate—osteoporosis	0.000447	0.00128	CcSEcCtD
Triazolam—Pain—Zoledronate—osteoporosis	0.000447	0.00128	CcSEcCtD
Triazolam—Nausea—Alendronate—osteoporosis	0.000446	0.00128	CcSEcCtD
Triazolam—Malaise—Estradiol—osteoporosis	0.000445	0.00127	CcSEcCtD
Triazolam—Hypersensitivity—Risedronate—osteoporosis	0.000444	0.00127	CcSEcCtD
Triazolam—Asthenia—Ethinyl Estradiol—osteoporosis	0.000443	0.00127	CcSEcCtD
Triazolam—Syncope—Estradiol—osteoporosis	0.000443	0.00127	CcSEcCtD
Triazolam—Nausea—Raloxifene—osteoporosis	0.000438	0.00126	CcSEcCtD
Triazolam—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000438	0.00125	CcSEcCtD
Triazolam—Pruritus—Ethinyl Estradiol—osteoporosis	0.000437	0.00125	CcSEcCtD
Triazolam—Palpitations—Estradiol—osteoporosis	0.000436	0.00125	CcSEcCtD
Triazolam—Fatigue—Conjugated Estrogens—osteoporosis	0.000434	0.00124	CcSEcCtD
Triazolam—Nausea—Ibandronate—osteoporosis	0.000434	0.00124	CcSEcCtD
Triazolam—Loss of consciousness—Estradiol—osteoporosis	0.000434	0.00124	CcSEcCtD
Triazolam—Asthenia—Risedronate—osteoporosis	0.000432	0.00124	CcSEcCtD
Triazolam—Feeling abnormal—Zoledronate—osteoporosis	0.000431	0.00123	CcSEcCtD
Triazolam—Constipation—Conjugated Estrogens—osteoporosis	0.000431	0.00123	CcSEcCtD
Triazolam—Pain—Conjugated Estrogens—osteoporosis	0.000431	0.00123	CcSEcCtD
Triazolam—Gastrointestinal pain—Zoledronate—osteoporosis	0.000428	0.00122	CcSEcCtD
Triazolam—Hypertension—Estradiol—osteoporosis	0.000426	0.00122	CcSEcCtD
Triazolam—Pruritus—Risedronate—osteoporosis	0.000426	0.00122	CcSEcCtD
Triazolam—Nausea—Calcitriol—osteoporosis	0.000425	0.00122	CcSEcCtD
Triazolam—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000423	0.00121	CcSEcCtD
Triazolam—Hypersensitivity—Pamidronate—osteoporosis	0.000422	0.00121	CcSEcCtD
Triazolam—Chest pain—Estradiol—osteoporosis	0.00042	0.0012	CcSEcCtD
Triazolam—Anxiety—Estradiol—osteoporosis	0.000419	0.0012	CcSEcCtD
Triazolam—Discomfort—Estradiol—osteoporosis	0.000415	0.00119	CcSEcCtD
Triazolam—Abdominal pain—Zoledronate—osteoporosis	0.000413	0.00118	CcSEcCtD
Triazolam—Diarrhoea—Risedronate—osteoporosis	0.000412	0.00118	CcSEcCtD
Triazolam—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000412	0.00118	CcSEcCtD
Triazolam—Dry mouth—Estradiol—osteoporosis	0.000411	0.00118	CcSEcCtD
Triazolam—Asthenia—Pamidronate—osteoporosis	0.000411	0.00118	CcSEcCtD
Triazolam—Dizziness—Ethinyl Estradiol—osteoporosis	0.000408	0.00117	CcSEcCtD
Triazolam—Confusional state—Estradiol—osteoporosis	0.000406	0.00116	CcSEcCtD
Triazolam—Pruritus—Pamidronate—osteoporosis	0.000405	0.00116	CcSEcCtD
Triazolam—Oedema—Estradiol—osteoporosis	0.000403	0.00115	CcSEcCtD
Triazolam—Dizziness—Risedronate—osteoporosis	0.000398	0.00114	CcSEcCtD
Triazolam—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000398	0.00114	CcSEcCtD
Triazolam—Shock—Estradiol—osteoporosis	0.000396	0.00113	CcSEcCtD
Triazolam—Tachycardia—Estradiol—osteoporosis	0.000393	0.00113	CcSEcCtD
Triazolam—Vomiting—Ethinyl Estradiol—osteoporosis	0.000393	0.00112	CcSEcCtD
Triazolam—Diarrhoea—Pamidronate—osteoporosis	0.000392	0.00112	CcSEcCtD
Triazolam—Hyperhidrosis—Estradiol—osteoporosis	0.00039	0.00112	CcSEcCtD
Triazolam—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000389	0.00111	CcSEcCtD
Triazolam—Headache—Ethinyl Estradiol—osteoporosis	0.000387	0.00111	CcSEcCtD
Triazolam—Hypersensitivity—Zoledronate—osteoporosis	0.000385	0.0011	CcSEcCtD
Triazolam—Vomiting—Risedronate—osteoporosis	0.000383	0.0011	CcSEcCtD
Triazolam—Dermatitis—Risedronate—osteoporosis	0.000379	0.00109	CcSEcCtD
Triazolam—Dizziness—Pamidronate—osteoporosis	0.000379	0.00108	CcSEcCtD
Triazolam—Headache—Risedronate—osteoporosis	0.000377	0.00108	CcSEcCtD
Triazolam—Asthenia—Zoledronate—osteoporosis	0.000375	0.00107	CcSEcCtD
Triazolam—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000371	0.00106	CcSEcCtD
Triazolam—Pruritus—Zoledronate—osteoporosis	0.00037	0.00106	CcSEcCtD
Triazolam—Nausea—Ethinyl Estradiol—osteoporosis	0.000367	0.00105	CcSEcCtD
Triazolam—Insomnia—Estradiol—osteoporosis	0.000364	0.00104	CcSEcCtD
Triazolam—Vomiting—Pamidronate—osteoporosis	0.000364	0.00104	CcSEcCtD
Triazolam—Paraesthesia—Estradiol—osteoporosis	0.000362	0.00104	CcSEcCtD
Triazolam—Asthenia—Conjugated Estrogens—osteoporosis	0.000361	0.00103	CcSEcCtD
Triazolam—Dermatitis—Pamidronate—osteoporosis	0.000361	0.00103	CcSEcCtD
Triazolam—Dyspnoea—Estradiol—osteoporosis	0.000359	0.00103	CcSEcCtD
Triazolam—Headache—Pamidronate—osteoporosis	0.000359	0.00103	CcSEcCtD
Triazolam—Somnolence—Estradiol—osteoporosis	0.000358	0.00103	CcSEcCtD
Triazolam—Diarrhoea—Zoledronate—osteoporosis	0.000358	0.00102	CcSEcCtD
Triazolam—Nausea—Risedronate—osteoporosis	0.000358	0.00102	CcSEcCtD
Triazolam—Pruritus—Conjugated Estrogens—osteoporosis	0.000356	0.00102	CcSEcCtD
Triazolam—Decreased appetite—Estradiol—osteoporosis	0.00035	0.001	CcSEcCtD
Triazolam—Fatigue—Estradiol—osteoporosis	0.000347	0.000994	CcSEcCtD
Triazolam—Dizziness—Zoledronate—osteoporosis	0.000346	0.00099	CcSEcCtD
Triazolam—Pain—Estradiol—osteoporosis	0.000345	0.000986	CcSEcCtD
Triazolam—Constipation—Estradiol—osteoporosis	0.000345	0.000986	CcSEcCtD
Triazolam—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000344	0.000986	CcSEcCtD
Triazolam—Nausea—Pamidronate—osteoporosis	0.00034	0.000973	CcSEcCtD
Triazolam—Dizziness—Conjugated Estrogens—osteoporosis	0.000333	0.000953	CcSEcCtD
Triazolam—Vomiting—Zoledronate—osteoporosis	0.000332	0.000952	CcSEcCtD
Triazolam—Feeling abnormal—Estradiol—osteoporosis	0.000332	0.000951	CcSEcCtD
Triazolam—Gastrointestinal pain—Estradiol—osteoporosis	0.000329	0.000943	CcSEcCtD
Triazolam—Dermatitis—Zoledronate—osteoporosis	0.000329	0.000943	CcSEcCtD
Triazolam—Headache—Zoledronate—osteoporosis	0.000328	0.000938	CcSEcCtD
Triazolam—Vomiting—Conjugated Estrogens—osteoporosis	0.00032	0.000916	CcSEcCtD
Triazolam—Abdominal pain—Estradiol—osteoporosis	0.000319	0.000912	CcSEcCtD
Triazolam—Dermatitis—Conjugated Estrogens—osteoporosis	0.000317	0.000908	CcSEcCtD
Triazolam—Headache—Conjugated Estrogens—osteoporosis	0.000315	0.000903	CcSEcCtD
Triazolam—Nausea—Zoledronate—osteoporosis	0.000311	0.000889	CcSEcCtD
Triazolam—Nausea—Conjugated Estrogens—osteoporosis	0.000299	0.000856	CcSEcCtD
Triazolam—Hypersensitivity—Estradiol—osteoporosis	0.000297	0.00085	CcSEcCtD
Triazolam—Asthenia—Estradiol—osteoporosis	0.000289	0.000828	CcSEcCtD
Triazolam—Pruritus—Estradiol—osteoporosis	0.000285	0.000816	CcSEcCtD
Triazolam—Diarrhoea—Estradiol—osteoporosis	0.000276	0.000789	CcSEcCtD
Triazolam—Dizziness—Estradiol—osteoporosis	0.000266	0.000763	CcSEcCtD
Triazolam—Vomiting—Estradiol—osteoporosis	0.000256	0.000733	CcSEcCtD
Triazolam—Dermatitis—Estradiol—osteoporosis	0.000254	0.000727	CcSEcCtD
Triazolam—Headache—Estradiol—osteoporosis	0.000252	0.000723	CcSEcCtD
Triazolam—Nausea—Estradiol—osteoporosis	0.000239	0.000685	CcSEcCtD
